NewAmsterdam Pharma Co N.V.·4

Feb 21, 5:00 PM ET

LANGE LOUIS G 4

4 · NewAmsterdam Pharma Co N.V. · Filed Feb 21, 2024

Insider Transaction Report

Form 4
Period: 2024-02-13
Transactions
  • Purchase

    Ordinary Shares

    2024-02-13$19.00/sh+5,000$95,00024,878 total(indirect: See Footnote)
Footnotes (1)
  • [F1]Represents ordinary shares acquired from the Company in an underwritten public offering. The ordinary shares acquired from the Company were placed into and are being held in a trust account for the benefit of the Reporting Person.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4